Skip to main content

Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids

European Radiology volume 30, pages 3869–3878 (2020)Cite this article

Abstract

Objectives

The clinical applicability of magnetic resonance image−guided high-intensity focused ultrasound (MR-HIFU) treatment of uterine fibroids is often limited due to inaccessible fibroids or bowel interference. The aim of this study was to implement a newly developed 3-step modified manipulation protocol and to evaluate its influence on the number of eligible women and treatment failure rate.

Methods

From June 2016 to June 2018, 165 women underwent a screening MRI examination, 67 women of whom were consecutively treated with MR-HIFU at our institution. Group 1 (n = 20) was treated with the BRB manipulation protocol which consisted of sequential applications of urinary bladder filling, rectal filling, and urinary bladder emptying. Group 2 (n = 47) was treated using the 3-step modified manipulation protocol which included (1) the BRB maneuver with adjusted rectal filling by adding psyllium fibers to the solution; (2) Trendelenburg position combined with bowel massage; (3) the manual uterine manipulation (MUM) method for uterine repositioning. A comparison was made between the two manipulation protocols to evaluate differences in safety, the eligibility percentage, and treatment failure rate due to unsuccessful manipulation.

Results

After implementing the 3-step modified manipulation protocol, our ineligibility rate due to bowel interference or inaccessible fibroids decreased from 18% (16/88) to 0% (0/77). Our treatment failure rate due to unsuccessful manipulation decreased from 20% (4/20) to 2% (1/47). There were no thermal complications to the bowel or uterus.

Conclusions

Implementation of the 3-step modified manipulation protocol during MR-HIFU therapy of uterine fibroids improved the eligibility percentage and reduced the treatment failure rate.

Trial registration

Registry number NL56182.075.16

Key Points

• A newly developed 3-step modified manipulation protocol was successfully implemented without the occurrence of thermal complication to the bowel or uterus.

• The 3-step modified manipulation protocol increased our eligibility percentage for MR-HIFU treatment of uterine fibroids.

• The 3-step modified manipulation protocol reduced our treatment failure rate for MR-HIFU treatment of uterine fibroids.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Abbreviations

BRB:

Bladder filling, rectal filling, bladder emptying

CE:

Contrast-enhanced

MR-HIFU:

Magnetic resonance image–guided high-intensity focused ultrasound

MRI:

Magnetic resonance imaging

MUM:

Manual uterine manipulation

NPV:

Non-perfused volume

SI:

Signal intensity

References

  1. Pron G (2015) Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser 15:1–86

    PubMed  PubMed Central  Google Scholar 

  2. Verpalen IM, Anneveldt KJ, Nijholt IM et al (2019) Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol 120:108700. https://doi.org/10.1016/j.ejrad.2019.108700

    Article  PubMed  Google Scholar 

  3. Duc NM, Keserci B (2018) Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids. Diagn Interv Radiol 24:283–291. https://doi.org/10.5152/dir.2018.18111

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fröling V, Kröncke TJ, Schreiter NF et al (2014) Technical eligibility for treatment of magnetic resonance-guided focused ultrasound surgery. Cardiovasc Intervent Radiol 37:445–450. https://doi.org/10.1007/s00270-013-0678-z

    Article  PubMed  Google Scholar 

  5. Behera MA, Leong M, Johnson L, Brown H (2010) Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril 94:1864–1868. https://doi.org/10.1016/j.fertnstert.2009.09.063

    Article  PubMed  Google Scholar 

  6. Arleo EK, Khilnani NM, Ng A, Min RJ (2007) Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol 18:681–685. https://doi.org/10.1016/j.jvir.2007.02.015

    Article  PubMed  Google Scholar 

  7. Zaher S, Gedroyc WM, Regan L (2009) Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids. Eur J Obstet Gynecol Reprod Biol 143:98–102. https://doi.org/10.1016/j.ejogrb.2008.12.011

    Article  PubMed  Google Scholar 

  8. Kim YS, Bae DS, Park MJ et al (2014) Techniques to expand patient selection for MRI-guided high-intensity focused ultrasound ablation of uterine fibroids. AJR Am J Roentgenol 202:443–451. https://doi.org/10.2214/AJR.13.10753

    Article  PubMed  Google Scholar 

  9. Kim YS, Lim HK, Rhim H (2016) Magnetic resonance imaging-guided high-intensity focused ultrasound ablation of uterine fibroids: effect of bowel interposition on procedure feasibility and a unique bowel displacement technique. PLoS One 11:e0155670. https://doi.org/10.1371/journal.pone.0155670

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. Park MJ, Kim YS, Rhim H, Lim HK (2013) Technique to displace bowel loops in MRI-guided high-intensity focused ultrasound ablation of fibroids in the anteverted or anteflexed uterus. AJR Am J Roentgenol 201:W761–W764. https://doi.org/10.2214/AJR.12.10081

    Article  PubMed  Google Scholar 

  11. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99:290–300. https://doi.org/10.1016/s0029-7844(01)01702-1

    Article  PubMed  Google Scholar 

  12. Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T (2007) Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol 196:184.e1–184.e6. https://doi.org/10.1016/j.ajog.2006.08.030

    Article  Google Scholar 

  13. Okada A, Morita Y, Fukunishi H, Takeichi K, Murakami T (2009) Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol 34:579–583. https://doi.org/10.1002/uog.7454

    CAS  Article  PubMed  Google Scholar 

  14. Saini S, Colak E, Anthwal S, Vlachou PA, Raikhlin A, Kirpalani A (2014) Comparison of 3% sorbitol vs psyllium fibre as oral contrast agents in MR enterography. Br J Radiol 87:20140100. https://doi.org/10.1259/bjr.20140100

    Article  PubMed  PubMed Central  Google Scholar 

  15. Klepac-Pulanic T, Venkatesan AM, Segars J, Sokka S, Wood BJ, Stratton P (2016) Vaginal pessary for uterine repositioning during high-intensity focused ultrasound ablation of uterine leiomyomas. Gynecol Obstet Invest 81:285–288. https://doi.org/10.1159/000441782

    Article  PubMed  Google Scholar 

  16. Jeong JH, Hong KP, Kim YR, Ha JE, Lee KS (2017) Usefulness of modified BRB technique in treatment to ablate uterine fibroids with magnetic resonance image-guided high-intensity focused ultrasound. Obstet Gynecol Sci 60:92–99. https://doi.org/10.5468/ogs.2017.60.1.92

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zhang L, Chen W, Liu Y et al (2010) Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol 73:396–403. https://doi.org/10.1016/j.ejrad.2008.11.002

    Article  PubMed  Google Scholar 

  18. Sainio T, Komar G, Saunavaara J et al (2018) Wedged gel pad for bowel manipulation during MR-guided high-intensity focused ultrasound therapy to treat uterine fibroids: a case report. J Ther Ultrasound 6:10. https://doi.org/10.1186/s40349-018-0116-4

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hesley GK, Felmlee JP, Gebhart JB et al (2006) Noninvasive treatment of uterine fibroids: early mayo clinic experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin Proc 81:936–942. https://doi.org/10.4065/81.7.936

    Article  PubMed  Google Scholar 

  20. Bonekamp D, Wolf MB, Roethke MC et al (2019) Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate. Eur Radiol 29:299–308. https://doi.org/10.1007/s00330-018-5584-y

    Article  PubMed  Google Scholar 

  21. Ko JKY, Seto MTY, Cheung VYT (2018) Thermal bowel injury after ultrasound-guided high-intensity focused ultrasound treatment of uterine adenomyosis. Ultrasound Obstet Gynecol 52:282–283. https://doi.org/10.1002/uog.18965

    CAS  Article  PubMed  Google Scholar 

  22. Hwang DW, Song HS, Kim HS, Chun KC, Koh JW, Kim YA (2017) Delayed intestinal perforation and vertebral osteomyelitis after high-intensity focused ultrasound treatment for uterine leiomyoma. Obstet Gynecol Sci 60:490–493. https://doi.org/10.5468/ogs.2017.60.5.490

    Article  PubMed  PubMed Central  Google Scholar 

  23. Chen J, Chen W, Peng S et al (2015) Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem 27:671–676. https://doi.org/10.1016/j.ultsonch.2015.05.031

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Department of Radiology, Isala Hospital, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands

    Inez M. Verpalen, Miranda van ‘t Veer-ten Kate, Erwin de Boer, Rolf D. van den Hoed & Martijn F. Boomsma

  2. Department of Gynecology, Isala, Zwolle, The Netherlands

    Joke M. Schutte & Jeroen R. Dijkstra

  3. Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands

    Arie Franx

  4. Image Sciences Institute, Imaging Division, University Medical Center Utrecht, Utrecht, The Netherlands

    Lambertus W. Bartels & Chrit T. W. Moonen

Authors
  1. Inez M. Verpalen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miranda van ‘t Veer-ten Kate
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erwin de Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rolf D. van den Hoed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joke M. Schutte
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jeroen R. Dijkstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arie Franx
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lambertus W. Bartels
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chrit T. W. Moonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Martijn F. Boomsma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Inez M. Verpalen.

Ethics declarations

Guarantor

The scientific guarantor of this publication is M.F. Boomsma, MD, PhD.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Prospective

• Experimental

• Performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 38742 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Verpalen, I.M., van ‘t Veer-ten Kate, M., de Boer, E. et al. Development and clinical evaluation of a 3-step modified manipulation protocol for MRI-guided high-intensity focused ultrasound of uterine fibroids. Eur Radiol 30, 3869–3878 (2020). https://doi.org/10.1007/s00330-020-06780-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-020-06780-2

Keywords

  • Uterine fibroids
  • MR-guided interventional procedures
  • High-intensity focused ultrasound ablation
  • Patient selection